-
Medical journals
- Career
News
Impact of Empagliflozin on the Risk of Cardiovascular Death and Need for Hospitalization Due to Heart Failure
10. 4. 2020 Source: DiabetesIn the EMPA-REG OUTCOME study, empagliflozin reduced the risk of cardiovascular death and the number of hospitalizations due to heart failure in patients with type 2 diabetes (T2DM) who had confirmed cardiovascular disease at study entry. In the following analysis, the authors focused on the benefit of empagliflozin in patients with different levels of risk for heart failure development.
Domestic application of biological asthma treatment improves quality of life and reduces doctor visits
The benefits of the possibility of home application of omalizumab, a monoclonal antibody indicated for patients with severe allergic asthma, are summarized by Dr. Jakub Novosad, Ph.D., from the…9. 4. 2020 Source: Asthma under control
Comparison of Efficacy and Safety of Unsaponifiable Soy and Avocado Oil and Chondroitin Sulfate in the Treatment of Knee Osteoarthritis
Osteoarthritis is the most common joint disease in adult patients, with its prevalence increasing with age, and these issues most frequently affect the knee joint. In the treatment of knee…8. 4. 2020 Source: Osteoarthritis Therapy
The Presence of COPD Worsens the Course of COVID-19 – Results of Epidemiological Studies
Among the at-risk populations during the current COVID-19 pandemic are older individuals and those suffering from chronic comorbidities. The presence of chronic obstructive pulmonary disease (COPD),…8. 4. 2020 Source: Treatment of Asthma and COPD
Are All Patients Really Suitable for Thromboprophylaxis Treated This Way?
A study published this year aimed to assess how often the risk of VTE is assessed in routine clinical practice in internally ill patients, what proportion of patients are suitable for…8. 4. 2020 Source: Thromboprophylaxis
Forgotten Pulmonologists: COVID-19 Detection in Patients with Lung Disease
The Czech Pneumological and Phthisiological Society of ČLS JEP (ČPFS) submitted a request to the Ministry of Health of the Czech Republic on March 25, 2020, to allow pulmonologists to send patients…7. 4. 2020 Source: Asthma under control
Direct Comparison of Ixekizumab and Adalimumab in Patients with Psoriatic Arthritis
The final results of the direct comparison of ixekizumab and adalimumab in the therapy of biologic-naïve patients with psoriatic arthritis were presented at the annual conference of the American…6. 4. 2020 Source: Biological Treatment
Quality of Nutrition in ICU and Subsequent Quality of Life Are Closely Related
In the past decade, there has been a reduction in mortality associated with severe sepsis or acute respiratory failure. However, the number of people requiring care in rehabilitation facilities,…6. 4. 2020 Source: Enteral Nutrition
Focused on the Effect of Teriflunomide on Lymphocyte Subpopulations
Teriflunomide is a common choice for long-term therapy of the relapsing-remitting form of multiple sclerosis. The use of this immunomodulatory agent results in a decrease in lymphocyte numbers. Its…6. 4. 2020 Source: Multiple Sclerosis
Efficacy and Safety of Soybean and Avocado Unsaponifiables in the Treatment of Knee and Hip Osteoarthritis
Osteoarthritis represents a chronic irreversible degenerative joint disease, the prevalence of which increases with age. Various approaches are applied in therapy, including the administration of…4. 4. 2020 Source: Osteoarthritis Therapy
Popular this week- Euthanasia at the Request of Patients With Dementia? Opinions Differ
- “Clinical Research Bites” – 2026/1
- Can AI Help Accelerate the Development of Antibiotics for Gonorrhea and MRSA?
- BioCog Test: Ten Minutes to Orient Yourself in a Patient’s Cognitive Status
- Reprogramming the Blood–Brain Barrier in an Alzheimer’s Disease Model
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career